Central serous chorioretinopathy
Fluid collects under the centre of the retina, often in stressed young men or people taking corticosteroids. Most cases clear alone in months.
What it is
A serous detachment of the neural retina at the macula from fluid leaking out of a hyperpermeable choroid through the pigment epithelium. It mainly affects adults aged 20 to 50, more often men, is linked to corticosteroids by any route and to stress, and most acute episodes clear within months.
Who gets it
Most common between 20 and 50 years, more often in men; recurrences are frequent.
Causes
- Corticosteroids by any route (oral, inhaled, nasal, skin, injections)
- Psychological stress and type A behaviour
- Pregnancy
- Cushing syndrome
- Obstructive sleep apnoea
Risk factors
- Male sex and age 20 to 50
- Corticosteroid use
- Stress
- Pregnancy
- Sleep apnoea
Pathophysiology
The choroid becomes congested and leaky; fluid passes through a weak point in the pigment epithelium and lifts the neural retina at the macula, shifting the photoreceptors forward.
Classification
- Acute (resolving within months)
- Chronic or recurrent
Symptoms and signs
- Blurred central vision in one eye
- A dark or grey central spot
- Objects look smaller (micropsia) or distorted
- Colours look washed out
Diagnosis
- Clinical
- Fundus examination shows a round, blister-like elevation at the macula.
- Tests
- Review all medications for corticosteroids; consider sleep apnoea and endocrine causes in recurrent cases.
- Imaging
- OCT shows subretinal fluid; fluorescein or indocyanine green angiography shows the leak.
Differential diagnosis
- Neovascular macular degeneration
- Optic disc pit maculopathy
- Uveitis with serous detachment (Vogt-Koyanagi-Harada)
- Choroidal tumour
Serous lift of the macula: central serous chorioretinopathy vs its look-alikes
| Feature | Central serous chorioretinopathy | Neovascular macular degeneration | Vogt-Koyanagi-Harada disease | Optic disc pit maculopathy |
|---|---|---|---|---|
| Typical patient | Adult aged 20 to 50, often male, stressed or on corticosteroids | Over 50 or 60, with drusen | Young adult with headache, tinnitus or hearing loss | Young adult with a congenital disc pit |
| Eyes | Usually one | Usually one at onset | Both | One |
| Blood or exudate | Absent | Often present | Absent; inflammatory cells in the eye | Absent |
| Angiography | Point leak rising or spreading into the blister | Leaking network of new vessels | Many pinpoint leaks with pooling in both eyes | Fluid tracks from the disc pit, little leak |
| Effect of corticosteroids | Worsens | No benefit | Main treatment | No benefit |
| Usual course | Clears in months; may recur | Progresses without injections | Responds to immunosuppression | Chronic; may need vitrectomy |
Goal of treatment
Allow spontaneous resolution, remove triggers and treat persistent fluid to protect the photoreceptors.
Treatment
- Lifestyle
- Stop or reduce corticosteroids where medically possible, with the prescribing doctor, and address stress and sleep.
- Follow-up
- Observation with OCT in acute cases.
- Procedure
- Photodynamic therapy or focal laser for chronic or recurrent cases.
Complications
- Chronic fluid and permanent central vision loss
- Recurrences
- Choroidal new vessels
Common traps
- Corticosteroids will settle a macular swelling of unknown cause: in central serous chorioretinopathy they worsen the leak, so steroid use by any route is stopped or reduced with the prescriber when possible, and steroids are not started for it
- Only oral corticosteroids count: inhaled, nasal, skin, joint and epidural steroids are all linked, so the medication history must ask about every route
- New blurred vision with a spot in a 55-year-old is probably central serous: after 50 a serous detachment may hide choroidal new vessels or polypoidal vasculopathy, which need angiography and anti-VEGF treatment
- Anti-VEGF injections are the first-line treatment: most acute episodes clear on their own; persistent or recurrent fluid is treated with photodynamic therapy or focal laser
- A sudden hyperopic shift means the glasses were wrong: the lifted retina sits closer to the lens, making the eye focus as if more long-sighted, which is a typical clue to subretinal fluid
Prognosis
Most acute episodes resolve with good vision; chronic disease can cause lasting damage.
Test yourself
Think of the answer, then tap the question to see it.
A 38-year-old man under work stress notices a grey spot and objects looking smaller in one eye. OCT shows subretinal fluid. Which question matters most in the history?
Any corticosteroid use by any route, including inhaled, nasal, skin and injected steroids, because it is the strongest modifiable trigger.
Why do objects look smaller in central serous chorioretinopathy?
Fluid lifts and stretches the retina, spreading the photoreceptors apart, so an image covers fewer of them and is perceived as smaller (micropsia).
A patient with bilateral serous retinal detachments also has headache, tinnitus and cells in the anterior chamber. Which diagnosis is more likely and why does it matter?
Vogt-Koyanagi-Harada disease. It is inflammatory and treated with corticosteroids, the opposite of central serous chorioretinopathy, which they worsen.
Fluid has persisted at the macula for several months despite stopping steroids. What is the next step?
Treatment to stop the leak, usually photodynamic therapy or focal laser guided by angiography, to protect the photoreceptors from lasting damage.
In ophthalmology
Connections
Educational information, not medical advice. For any symptom, see a health professional.
Sources: Central Serous Chorioretinopathy (StatPearls Publishing (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.

